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Abstract 
The aim of this work was to develop drug-soft contact lens combination products suitable for 
controlled release of antimicrobial peptides on the ocular surface. Incorporation of functional 
monomers and the application of molecular imprinting techniques were explored to endow 
2-hydroxyethyl methacrylate (HEMA) hydrogels with the ability to load and to sustain the 
release of polymyxin B and vancomycin. Various HEMA:drug:functional 
monomer:crosslinker molar ratios were evaluated to prepare polymyxin B imprinted and 
non-imprinted hydrogels. Acrylic acid-functionalized and imprinted hydrogels loaded 
greater amounts of polymyxin B and led to more sustained release profiles, in comparison to 
non-functionalized and non-imprinted networks. Polymyxin B-loaded hydrogels showed 
good biocompatibility in HET-CAM tests. Functionalized hydrogels also loaded vancomycin 
and sustained its release, but the imprinting effect was only exhibited with polymyxin B, as 
demonstrated in rebinding tests. Microbiological assays carried out with Pseudomonas 
aeruginosa allowed identification of the most suitable hydrogel composition for efficient 
bacteria eradication; some hydrogels being able to stand several continued challenges against 
this important bacterial pathogen. 
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INTRODUCTION 
Efficient topical ocular drug delivery is a still challenging task due to the numerous barriers 
that prevent drug penetration through the cornea.1 Maintenance of therapeutic levels for a 
long time, as required for antimicrobial treatments, is not fully achieved using traditional eye 
drops. In-situ forming gels, suspensions, muco-adhesive polymers, nanoparticles and 
implants have been shown to enhance, to a certain extent, ocular drug bioavailability, as long 
as they can prolong drug residence on the ocular surface or promote its penetration.2-4 
Nevertheless, discomfort symptoms caused by the formulation itself, like sticking and 
blurring effects, do not facilitate patient compliance. Using soft contact lenses as drug 
delivery platforms can minimize these drawbacks, while significantly increase ocular 
bioavailability by entrapping the drug in the lachrymal fluid between the lens and the 
cornea.5-7 It should be noticed that hydrogel contact lenses can be used not only for vision 
correction, but also as neutral corneal bandages for improving healing processes.8  
In general, commercially available contact lenses are quite hydrophilic networks and exhibit 
limited affinity for most ophthalmic drugs. As a consequence, the amount of drug loaded 
cannot reach therapeutic levels in the cornea or it is released too fast and prolonged effects 
cannot be attained. By contrast, a few lens types bear components that strongly bind certain 
drugs, which hinders complete release when in contact with the lachrymal fluid.9 Therefore, 
the design of drug-contact lens combination products requires an adequate match of the 
chemical functionalities of the contact lens network with those of the drug to be delivered, 
while preserving the unique light transparency and oxygen permeability of the contact 
lenses.10,11. In recent years, several new strategies have been explored to endow contact 
lenses with tunable affinity for drugs.10 Amongst these strategies, the use of small proportions 
of monomers, which bear chemical groups complementary to those of the drug of interest 
(named functional monomers), is a promising advance, as these can be easily copolymerized 
with the main backbone monomers routinely used to prepare contact lenses. The functional 
monomers must be chosen such that they do not significantly alter the physical properties 
and the biocompatibility of the lenses. This approach can benefit from the application of the 
molecular imprinting technology, which aims to optimize the affinity for the drug by means 
of the appropriate arrangement of those functional monomers.12,13 To ’imprint’ a polymer, 
the target drug molecules are used as templates around which the monomers organize as a 
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function of their binding interactions. Subsequent polymerization fixes these binding 
arrangements in place and, when the templates are removed, receptors (imprinted cavities) 
that are chemically and spatially complementary to the template molecule are revealed. 
Imprinting of small molecules in rigid polymer networks is now well developed and also 
incipiently proved in swellable hydrogels.12,14,15 However, preparation of hydrogels 
imprinted for peptide drugs is still challenging for two main reasons: (i) the peptide has to be 
soluble in the monomer solution and be able to diffuse through the network during removal 
and rebinding (which is difficult due to steric hindrance of the network mesh size); and (ii) 
the relatively low cross-linking density of the contact lenses and their swelling in aqueous 
media (including lachrymal fluid) after polymerization may reduce the stability of the 
imprinted cavities.16 Therefore, the imprinting procedure should be designed to yield the 
optimum network stability and maximum interactions between the drug and the network.17 
Among other applications, antimicrobial peptides are being used for the treatment of severe 
ocular infections, when formulated as solutions or suspensions that incorporate thickening 
agents in order to enhance the residence time on the cornea.18 Polymyxin B, a lipopeptide 
antibiotic that can electrostatically interact with the negatively charged lipopolysaccharide 
(LPS), exhibits a rapid activity against multidrug-resistant Gram-negative bacteria, such as 
Pseudomonas aeruginosa.19 Ophthalmic eye drops containing polymyxin B solely or in 
combination with trimethoprim are commercially available and intended for treatment of 
multidrug-resistant pathogens.20,21 To the best of our knowledge, delivery of polymyxin B 
using contact lenses has not been evaluated yet. Moreover, no previous attempts to prepare 
imprinted networks for polymyxin B have been carried out, although a polymerizable 
derivative of polymyxin B has been used as functional monomer to develop a sensor for 
detection of LPS in sepsis, which relies on the strong affinity of this antimicrobial peptide 
for LPS.22 Thus, the aim of our work was to develop hydrogel contact lenses suitable for 
loading and release of therapeutic amounts of polymyxin B and related antimicrobial peptide 
drugs, such as vancomycin. To do that, 2-hydroxyethyl methacrylate (HEMA) (a common 
component of soft contact lenses) was copolymerized with low proportions of acrylic acid 
(AAc), acting as functional monomer, at various monomer:template:crosslinker ratios. 
Imprinted and non-imprinted hydrogels series were prepared, and each set of hydrogels was 
characterized paying special attention to the drug loading/release capability and also to the 
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maintenance of optical properties, oxygen permeability and other features critical for the 
performance as soft contact lenses. Memorization of the imprinting effect and effectiveness 
against Pseudomonas aeruginosa were also investigated.    
 
MATERIALS AND METHODS 
Materials 
Ophthalmic grade 2-hydroxyethyl methacrylate (HEMA) and acrylic acid (AAc) were from 
Merck (Germany); 2,2′-azo-bis-isobutyronitrile (AIBN) from Acros (New Jersey, USA); 
ethyleneglycol dimethacrylate (EGDMA) and dichlorodimethylsilane from Sigma-Aldrich 
(Germany); vancomycin HCl from Fagron (Spain); and polymyxin B sulfate from Alfa Aesar 
(Germany). Ultrapure water was obtained by reverse osmosis (resistivity>18.2 MΩ cm; 
Milli-Q®, Millipore, Spain). 
 
Hydrogel preparation 
HEMA (4.5 mL) was transferred to vials containing different amounts of polymyxin B, and 
then AAc, water and EGDMA were added in the proportions indicated in Table 1. AIBN (10 
mg) was incorporated to the vials and the systems were stirred until complete dissolution. 
The solutions were then injected into moulds made of two glass plates previously treated 
with dichlorodimethylsilane and separated by a silicon frame (0.4 mm thickness). The 
moulds were kept at 50˚C for 12 h and then at 70 ˚C for 24 h to complete the polymerization 
of the hydrogel films. Each hydrogel was boiled in water for 30 min to remove un-reacted 
monomers. A cork borer was used to take discs out of the hydrogels (10 mm in diameter). 
The discs were immersed in water and the absorbance of the supernatant was monitored by 
UV spectrophotometry (Agilent 8453, Germany) to detect removal of polymyxin B used as 
template. Water was replaced until the discs were clean. All discs were then immersed in 
phosphate buffer pH 7.4 for 24 hours, rinsed with water and dried at 37 ˚C for 12 h. 
 
 
 
Hydrogels physical characterization 
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Differential scanning calorimetry (DSC) runs of polymyxin B and hydrogel discs (2-4 mg) 
were recorded in a DSC Q-100 (TA instruments, UK) heating from room temperature to 
100°C, cooling from 100°C to 0°C, and finally heating from 0°C to 300°C at 10°C/min. 
Transmittance of hydrogel pieces was recorded in the 200 nm to 700 nm range using a UV 
spectrophotometer (Agilent 8453, Germany). Oxygen permeability (Dk) and transmissibility 
of hydrogels previously swollen in 0.9% NaCl solution were measured in triplicate using a 
Createch permeometer (model 210T, Rehder Development Company, Castro Valley, USA) 
fitted with a flat polarographic cell and in a chamber at 100 % relative humidity. Degree of 
swelling was evaluated in water and in 0.9% NaCl solution. Dry discs were weighed (Wd) 
and placed in the aqueous medium at room temperature. At various time points they were 
removed from the medium, the surface was wiped with a piece of paper and the weight 
recorded again (Ws). The degree of swelling was calculated as follows: 
𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 (%) =
(𝑊𝑠−𝑊𝑑)
𝑊𝑠
· 100    (1) 
 
Polymyxin B loading and release 
Three discs of each hydrogel type (weights ranging from 0.033g to 0.042g) were immersed 
independently in 2 mL of polymyxin B solution (4 mg/mL) prepared in previously autoclaved 
water (121ºC, 30 min). The systems were kept protected from light at room temperature, and 
the absorbance of loading solutions was monitored at 258 nm (UV spectrophotometer, 
Agilent 8453, Germany). The amount of polymyxin B loaded was calculated from the decay 
in absorbance and referred to the weight of each disc. After 3 days in the loading solution, 
the discs were removed, wiped with a piece of paper, and immediately transferred to vials 
containing 2 mL of 0.9% NaCl solution also prepared using autoclaved water. Samples of 
release media were frequently withdrawn to measure drug concentration using UV-Vis 
spectrophotometry (258 nm); the samples were then returned to the vials. The amount of drug 
(mg) released per gram of disc was calculated. After 174 hours the discs were weighed and 
transferred to fresh release media. In all cases, the release tests were carried out under sink 
conditions. 
 
 
Vancomycin loading and release 
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Three discs of each hydrogel type were immersed independently in 2 mL of vancomycin 
aqueous solution (4 mg/mL) at room temperature. The systems were kept protected from 
light at room temperature, and the absorbance of loading solutions was monitored at 281 nm 
(UV spectrophotometer, Agilent 8453, Germany). The amount of vancomycin loaded was 
calculated from the decay in absorbance and referred to the weight of each disc. For the 
release test, vancomycin-loaded discs were removed from the loading solution, wiped with a 
piece of paper and placed in water for one day and then moved to 2 mL of 0.9% NaCl 
solution. Samples of release media were frequently withdrawn to measure drug concentration 
using UV-Vis spectrophotometry (281 nm); the samples were then returned to the vials. The 
amount of drug (mg) released per gram of disc was calculated. After 47 hours the discs were 
weighed and transferred to fresh media, and the release study continued as described above. 
 
Polymyxin B loading and release after vancomycin release 
The discs were thoroughly washed with water after the vancomycin release study in order to 
ensure a complete removal of the drug. Then, they were immersed in phosphate buffer pH 
7.4 for 24 hours, rinsed with water and dried at 37 ˚C for 12 h. Polymyxin B loading and 
release tests were carried out as described above.  
 
Microbiological tests 
Non-loaded and polymyxin B-loaded hydrogel discs were placed on plates containing 
Müller-Hinton agar, previously seeded with Pseudomonas aeruginosa CECT 110 (Spanish 
Type Culture Collection) grown in tryptic soy agar (TSA1). The plates were then kept at 38 
°C for 24 hours and after measuring the inhibition zones, the hydogels were transferred to 
new plates seeded as described above and incubated in the same way. The inhibition zones 
were measured again. In parallel, the antimicrobial effects of samples of release medium 
from polymyxin B-loaded contact lenses, which were collected after 4 and 8 hours of the 
beginning of the release test, were measured by placing 20 µL onto paper discs (6 mm in 
diameter; Whatman, Sigma-Aldrich, St. Louis MO, USA) placed on similar plates also 
seeded with Pseudomonas aeruginosa. After 24 h of incubation, the inhibition zones were 
measured. 
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HET-CAM Tests 
The ICCVAM-recommended hen’s egg test-chorioallantoic membrane test (HET-CAM) 
method protocol23 was followed, as previously described.24 Briefly, fertilized broiler chicken 
eggs (Coren, Spain) were incubated at 37 ± 0.3 ºC and 60 ± 2.6% relative humidity until day 
10. Then, the upper part of the eggshell was removed using a rotary saw (Dremel 300, Breda, 
The Netherlands) and the intact inner membrane of the eggs was moistened with 0.9% (w/v) 
NaCl solution for 30 min and then detached with a forceps. Polymyxin B-loaded hydrogel 
discs were placed on the chorioallantoic membrane and the irritation potential was monitored 
for 5 min. The experiments were carried out in triplicate. Negative (0.9% NaCl solution) and 
positive (0.1 N NaOH) controls were performed under the same conditions. Irritation scores 
(IS) were calculated as follows:  
 
IS = [(
301−𝐻𝑡𝑖𝑚𝑒
300
) x 5 + (
301−𝐿𝑡𝑖𝑚𝑒
300
) x 7 + (
301−𝐶𝑡𝑖𝑚𝑒
300
) x 9]  (2) 
In this equation, Htime, Ltime and Ctime represent the time (in seconds) at which hemorrhage, 
lysis and/or coagulation started. 
 
RESULTS AND DISCUSSION 
Hydrogels preparation and physical properties 
Polymyxin B, as well as other cationic polypeptides, performs as an antimicrobial agent due 
to its capability to bind into the cell membrane of Gram-negative bacteria and, as a 
consequence, to alter its permeability. Solely or combined with trimethoprim, polymyxin B 
is used in ophthalmic drops at 1 mg (equivalent to 10,000 units) per mL, and one drop should 
be instilled every three hours (up to 6 doses per day) for 7 to 10 days.25 Polymyxin B consists 
of a mixture of five structurally-related components (B1, B1-I, B2, B3 and B6), which posses 
an identical polypeptide head and a slightly different fatty acid tail (Figure 1) and, thus, show 
very similar MIC values.26 As a related antimicrobial agent, vancomycin is a bulkier 
glycosylated peptide (Figure 1) that cannot penetrate Gram-negative bacteria membranes 
(except some Neisseria spp.) but binds to the terminal D-alanyl-D-alanine moieties of the 
wall of Gram-positive bacteria, hindering their cross-linking. Detailed studies on the 
interaction of vancomycin with acrylic acid (AAc), a suitable monomer for contact lenses 
which can also perform as functional monomer for imprinted networks, revealed that in an 
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aqueous environment AAc strongly binds to the primary amino and amido groups, but also 
at the secondary amino groups up to a drug:AAc stoichiometry of ca. 1:10.27 Polymyxin B 
has five primary amino and eleven secondary amino groups, as well as a large number of 
carbonyl groups that can establish hydrogen bonds with AAc (Figure 1). Thus, to prepare the 
hydrogels, AAc amount was fixed in 0.2 mL in order to have an AAc:HEMA ratio of approx. 
1:12.5 mol/mol (i.e., 8 mol% in AAc), which is a common proportion when preparing ionic, 
hydrophilic contact lenses.10 In addition to one control non-imprinted hydrogel (A in Table 
1), three different amounts of polymyxin B (12.5, 25, and 50 mg) were tested to obtain 
imprinted networks, which led to AAc:drug ratios of 288, 144, and 72 mol/mol. To avoid 
solubility problems, HEMA was first added to the drug powder in vials and then AAc was 
added solely or with a small volume of water, and afterwards the other components were 
incorporated. Addition of water was only tested for one of the hydrogels (F) prepared with 
the largest content in template drug, and its effect was compared to that of a hydrogel with a 
similar composition without water (G). Such a high proportion of polymyxin B took several 
hours to be totally solubilized; water shortening the process. The cross-linker EGDMA was 
incorporated at 4.4 mol% with respect to HEMA (as it is common when preparing soft 
contact lenses) and, in hydrogel D, at 2.2 mol% in order to elucidate if a less cross-linked 
network may allow a faster and more complete diffusion of polymyxin B. In total, seven 
different compositions were tested to prepare the hydrogels as indicated in Table 1.  
 
The melting point of polymyxin B sulfate, ca. 235 ºC, was not seen after hydrogel synthesis 
which indicated complete dissolution of the drug in the monomers solution. Moreover DSC 
scans of the hydrogels (Figure S1 in Supporting Information) showed the typical glass 
transition of HEMA networks close to 110 ºC.28 Nevertheless, hydrogels prepared with the 
greatest content in polymyxin B were translucent and showed a limited light transmittance; 
namely, ca. 45%, 25% and 15% transmittance for hydrogel E, F and G, respectively, in the 
300 to 600 nm range. This finding suggests a phase separation process (probably due to ionic 
interactions of polymyxin B with AAc) that may limit the use of these hydrogels as contact 
lenses, although it should be noticed that the thickness of the discs (0.4 mm) is greater than 
the central thickness of common contact lenses (0.07 mm to 0.35 mm depending on power). 
Therefore for thinner lenses, the detrimental effect on light transmittance may be attenuated. 
10 
 
Regarding oxygen permeability, all hydrogels exhibited typical values of soft contact 
lenses;29 ranking in the order hydrogel C [65·10-11 cm3·cm2/(cm3·s·mmHg)] < E ≈ F≈ G ≈ 
B≈ A [70·10-11 cm3·cm2/(cm3·s·mmHg)] < D [80·10-11 cm3·cm2/(cm3·s·mmHg)]. This order 
correlates well with the degree of swelling of the hydrogels (Table 2). 
 
Polymyxin B loading  
Polymyxin B loading profiles (Figure 2) clearly indicated that the functional monomer AAc 
is required for the uptake of the drug by the hydrogels. Hydrogel C, the only one synthesized 
without AAc but polymerized in the presence of the drug, did not show any affinity for 
polymyxin B. This means that the template drug molecules by themselves did not improve 
the subsequent loading; hydrogel C swelled in the loading medium without perturbing drug 
concentration, which means that polymyxin B concentration in the aqueous phase inside the 
hydrogel is the same as in the loading solution and no drug adsorption to the polymer 
backbone occurs.30 In contrast, hydrogel D which was imprinted with the smallest amount of 
drug (12.5 mg) and cross-linked with the lowest proportion of EGDMA, exhibited a very 
rapid and remarkably high drug loading. As mentioned above, except for hydrogel C, all 
networks contained a fixed proportion of AAc. Therefore, the rapid uptake observed in the 
case of hydrogel D can be attributed to its greater mesh size (because of the lower cross-
linking density), which in turn makes diffusion of the peptide drug into the network easier 
and facilitates the interaction with the available acrylic acid groups. In fact, hydrogel D was 
the one that swelled more both in water and in 0.9% NaCl medium (Table 2). If compared 
with the AAc-functionalized non-imprinted hydrogel A, the hydrogels B, E and G imprinted 
with 12.5, 25 or 50 mg drug, respectively (Table 1), loaded somehow less drug, which is not 
uncommon for imprinted networks.31 Interestingly, just adding a small volume of water to 
the monomers before polymerization (hydrogel F) remarkably facilitated the loading 
(compared to hydrogel G). The small volume of water added favored drug dissolution and 
interaction with AAc before polymerization, and it may also increase hydrogel mesh size 
without leading to pores formation.32 In summary, proportions of AAc, cross linker, drug and 
water play all an important role in the polymyxin B loading performance of the hydrogels. 
The loading study was limited to 3 days in order to avoid drug instability problems. The 
maximum loading, recorded for hydrogels D and F, was around 90 mg drug per gram of disc, 
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which corresponds to an AAc:drug 10:1 mol ratio. For a disc with weight (around 15 mg) 
and dimensions similar to those of a soft contact lens, this loading may correspond to 1.35 
mg polymyxin B per lens, which is roughly equivalent to the amount provided by 27 drops 
of 50 µL commercial eye drops. 
 
To quantify the increase in affinity provided by the functional monomer and the molecular 
imprinting approach, the partition coefficient of polymyxin B between the hydrogel network 
and water, Kn/w, was calculated as follows:
30 
 
𝐾𝑛/𝑤 =
𝑇𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡  (
𝑚𝑔
𝑔
)−𝐴𝑚𝑜𝑢𝑛𝑡 𝑖𝑛 𝑡ℎ𝑒 𝑎𝑞𝑢𝑒𝑜𝑢𝑠 𝑝ℎ𝑎𝑠𝑒 (
𝑚𝑔
𝑔
)
𝐶0(
𝑚𝑔
𝑔
)
 (3) 
In this equation, “total amount” represents the amount of drug loaded by the hydrogel (mg 
drug/g), “amount in the aqueous phase” is the amount of drug in the aqueous phase of the 
hydrogel estimated as the product of the water volume absorbed by the hydrogel (mL 
water/g) and the concentration of the drug in the soaking solution (mg drug/mL water). This 
later concentration is C0 assuming that water density is 1 mg/mL. 
Compared to hydrogel C (which did not contain AAc), all other hydrogels showed approx. 
10-times greater Kn/w values (Table 2), which means that the functional monomer increased 
10-fold the affinity of the network for the drug in spite of being incorporated at a low 
proportion. No significant differences were recorded between hydrogels A and B, which 
means that addition of a low amount of polymyxin B as template during polymerization has 
minimal repercussion on the total rebinding of the drug. The highest Kn/w values were 
recorded for hydrogels D and F, which respectively indicate that an increase in mesh size 
(low cross-linker proportion in hydrogel D) and incorporation of more template molecules 
(and also a small amount of water to facilitate dissolution and interaction with functional 
monomers, in hydrogel F) favor the access to, and the interaction with, the network of the 
antimicrobial peptide drug. In fact, regarding Kn/w values hydrogels with a fixed EGDMA 
proportion ranked in the order: B < E  G < F; namely, the greater the proportion of template 
molecules, the highest the Kn/w value. 
 
Polymyxin B release 
12 
 
Polymyxin B-loaded discs were removed from the soaking solution, wiped with a piece of 
paper to remove excess loading medium, and immediately transferred either to release 
medium (0.9% NaCl) or to agar plates seeded with Ps. aeruginosa (as discussed below). 
Moreover, samples of release medium were taken at 4 and 8 hours in order to check their 
antimicrobial activity. It should be noticed that this bacteria is the most common pathogen in 
contact lens-related ocular infections.33  
Release profiles (depicted in Figure 3) were in all cases recorded under sink conditions and 
the release medium was not exchanged in the first days of the test in order to investigate the 
effects of the affinity of the lens for the drug on the release process. Thus, differences in 
release rate can attributed to differences in affinity and not to solubility restrictions. As 
expected, hydrogel C only released a minimal amount of drug, which corresponded to that 
hosted in the aqueous phase of the network, and the delivery occurred in few hours. This 
hydrogel exhibited the fastest release rate, also in agreement with an unspecific loading. 
Interestingly, when placed on Ps. aeruginosa plates a small inhibition zone was recorded 
(Figure 4; Table 2) which corresponded to the rapid release of its small payload. Hydrogel C 
did not stand a second challenge against the bacteria. 
The other hydrogels sustained the release for more than two weeks, even though the 0.9% 
NaCl medium weakened the drug-polymer interactions. Compared to the non-imprinted 
hydrogel A, release profiles from hydrogels G and F (prepared with AAc:drug ratios of 72 
mol/mol and, in the last case, incorporating water) were quite similar, but hydrogels B and E 
showed more sustained release (Figure 3). This means that adding small amounts of 
polymyxin B during synthesis (AAc:drug ratios of 288 and 144 mol/mol, respectively), 
enables the arrangement of AAc mers in a more favorable conformation for drug retention. 
In fact, hydrogel B exhibited the slowest release. It seems that for hydrogels G and F, the 
amount of template is in excess for creating well-defined imprinted cavities and thus no 
differences with the non-imprinted polymers in release rate can be detected.  
The behavior of hydrogel D (homologous to B but with cross-linker reduced by 50%) was 
again different to the others, and led to the second faster release profile; at day 7, hydrogel D 
released 71% drug loaded compared to hydrogel B that only released 41%. The lower 
crosslinking density should not only facilitate drug diffusion, but also compromise the 
physical stability of the imprinted cavities. Hydrogel D swelled more than the other hydrogels 
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both in the loading and the release media, and thus the imprinted cavities could be distorted 
more greatly than in hydrogel B. These results are in agreement with previous reports that 
indicate that if the cross-linker proportion is below the proportion in functional monomers, 
imprinted cavities fail in maintaining the conformational memory engraved upon synthesis.34  
 
With the exception of hydrogel C, all other hydrogels avoided the growth of Ps. aeruginosa 
on their surface and led to remarkable inhibition zones on agar plates (Figure 4). In agreement 
with the loading and release profiles, hydrogel D caused the greatest inhibition of bacteria 
growth. The differences with respect to the other hydrogels were even larger when the same 
hydrogel discs were exposed to a second challenge with the bacteria (Table 2). Its counterpart 
formulation, hydrogel B, led to smaller inhibition diameters, as expected from its slower 
release of the drug. Thus, this microbiological test appears as a suitable tool for 
discriminating hydrogels regarding loading and release of polymyxin B. Overall, the large 
inhibition zones recorded for all AAc-functionalized hydrogels even after the second 
challenge clearly indicates that this monomer, at proportions suitable for preparing soft 
contact lenses, endows the hydrogels with affinity for polymyxin B sufficient to provide drug 
levels well above the minimum inhibitory concentration (MIC) of Ps. aeruginosa. Although 
the differences among the imprinted hydrogels were small, once again the inhibition zones 
recorded in the two challenges were greater for those hydrogels prepared with more template 
molecules, which can be related to their greater loading and relatively faster release of 
polymyxin B.  
Since testing the hydrogels on agar plates allows release of the drug for the full 24 h of 
incubation of each challenge, an additional test was carried out to analyze the capability of 
polymers which released the drug over shorter times (4 and 8 h) to inhibit bacterial growth. 
Thus, samples of the release medium were taken at 4 and 8 h and placed on sterile paper disk 
on the bacteria culture. Samples taken at 4 h did not show distinguishable inhibition zones 
around the paper disc with the exception of those coming from release medium of hydrogel 
D (Figure 4). After 8 h of release, samples from hydrogel C release medium still did not 
cause any inhibition and in fact the bacteria grew well all around the paper disc. Samples 
from hydrogels A, B, E, F, and G showed a small inhibition zone, similar to that observed 
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for hydrogel D at 4 h. Once again, samples of release medium from hydrogel D at 8 h were 
the ones that provided the highest bacteria inhibition. 
Preliminary evaluation of the biocompatibility of polymyxin B-loaded hydrogels was carried 
out using the HET-CAM assay, which has been proposed as an alternative method of Draize 
eye irritation test by the ICCVAM.23 It is important to note that none polymyxin B-loaded 
hydrogels caused hemorrhage, lysis or coagulation in the chorioallantoic membranes, which 
suggests adequate biocompatibility in spite of their potent antibacterial effect. 
 
Vancomycin loading and release 
Hydrogels were also tested regarding their affinity for vancomycin in order to elucidate 
whether the loading and release behavior exhibited with polymyxin B could be extrapolated 
to other related antimicrobial peptide drugs. Structural similarities/differences among related 
drugs may favor/hinder the loading especially in the imprinted cavities. Moreover, selectivity 
and memorization of the imprinting effect attained for polymyxin B can be investigated by 
first loading and release of vancomycin and, subsequently, monitoring the loading and 
release of polymyxin B with the same hydrogel discs.  
In contrast to polymyxin B, vancomycin exhibits a broad spectrum against Gram-positive 
bacteria and is the first-choice antimicrobial agent against methicillin-resistant 
Staphylococcus aureus (MRSA). Both polymyxin B and vancomycin have a similar 
molecular size, but vancomycin is a stronger base (pKa 8.89)35 and bears more aromatic rings 
(Figure 1). Therefore, each of these molecules should fit differently into the imprinted 
cavities. When monitoring the loading of vancomycin (Figure 5), it was again observed that 
hydrogel C did not uptake drug while hydrogel D was the one that loaded the drug faster, as 
happened with polymyxin B. As indicated above, this means that the functional monomer 
AAc is mandatory to endow the networks with affinity for the peptide drugs, and that a low 
cross-linking density facilitates the diffusion of the drug. However, two remarkable 
differences can be observed: (i) hydrogel D was the one that loaded more; and (ii) all other 
hydrogels (except C) either imprinted or non-imprinted loaded the same. These findings 
indicate that, for a fixed cross-linker proportion (hydrogels A, B, E, F and G), vancomycin 
loading is only driven by the interaction with AAc (which is quite strong as previously 
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reported)27 and vancomycin molecules interact the same with the AAc in the non-imprinted 
orientation and in the cavities imprinted for polymyxin B. Thus, vancomycin did not adjust 
well into the polymyxin B-imprinted regions. In rigid, highly-crosslinked networks the lack 
of affinity for the imprinted cavities is commonly shown as a decrease in the amount loaded 
because the movement of the functional monomers is strongly restricted.36 In the case of 
loosely cross-linked networks, as it is the case of swellable soft contact lenses, the 
arrangement of the functional monomers upon synthesis can be distorted in the presence of 
a strong interacting molecule. As a consequence, imprinted and non-imprinted networks 
behave the same against a non-imprint drug (vancomycin in the present case).  
Performance of the hydrogels during the release confirmed the loss of the imprinting effect 
in the presence of vancomycin. The vancomycin-loaded discs were first immersed in water 
and no release occurred for 1 h, which confirmed the strength of the drug-network 
interactions. When transferred to 0.9% NaCl, the release was triggered due to competitive 
displacement of the drug by ions of the medium, but almost stopped 24 h latter, which 
indicated that an equilibrium was attained between the drug molecules free in the medium 
and those interacting with the network (as previously observed for networks of diverse 
composition).37,38 It should be noticed that all release experiments were carried out under 
sink conditions. Therefore, the discontinuation in the release confirms the strength of 
vancomycin-AAc interaction. Exchange of the release medium with fresh 0.9% NaCl 
allowed the release to commence again.  
Regarding hydrogel composition, no appreciable differences were observed among the 
various imprinted and non-imprinted hydrogels prepared with fixed cross-linker proportion 
(hydrogels A, B, E, F and G). That is to say, the imprinting effect observed for polymyxin B 
disappeared in the case of the non-imprint vancomycin. Interestingly and oppositely to what 
had been observed for polymyxin B, hydrogel D was the one that released the drug more 
slowly. This hydrogel showed a higher loading of vancomycin than of polymyxin B, which 
again confirms that vancomycin did not accommodate in the imprinted cavities, but directly 
interacted with AAc functionalities. From consideration of the greater accessibility of AAc 
units in hydrogel D because of its lower cross-linking density, it is likely that during the 
release experiments, the drug molecules were able to find more AAc binding points and be 
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temporally retained before reaching the surface of the hydrogel. This mechanism is typical 
of an affinity-controlled release process and has been previously described for cyclodextrin 
networks.37,38  
 
Polymyxin B re-loading and release 
From a theoretical point of view, evaluation of the ability of hydrogels that were exposed to 
vancomycin to recover the same affinity for polymyxin B as they initially had after synthesis, 
may provide useful information regarding the “memorization” of the imprinting 
conformation in loosely cross-linked networks. From a practical point of view, it could help 
to foresee the possibility of reuse of the same hydrogel discs for successive loading and 
release of peptidic drugs. Polymyxin B loading profiles of re-used discs (Figure 6) followed 
the same ordering as that shown by freshly prepared discs (Figure 2). Although the total 
amount loaded by the imprinted networks was slightly lower, it again ranked in the order B 
< E  G < F. This suggests that the imprinted cavities recovered their conformation upon 
synthesis, which can occur through an induced fit mechanism when polymyxin B molecules 
interact with the imprinted regions, as previously suggested for other imprinted hydrogel 
systems.39 Polymyxin B release profiles (Figure 6) also resembled those recorded for freshly 
prepared discs (Figure 3), although the re-used hydrogels exhibited slightly higher release 
rate, which may indicate that the reconstituted imprinted cavities are less spatially-defined 
than the pristine ones. Thus, they cannot retain the drug so strongly. Nevertheless, the re-
used hydrogels still sustained the release of drugs for two weeks.  
 
CONCLUSIONS 
Acrylic acid (AAc) is suggested as a valuable monomer for preparing soft contact lenses able 
to load and release therapeutically useful doses of peptidic antimicrobial agents. The 
proportion of AAc is in the range commonly used to prepare hydrogel lenses and therefore it 
does not alter physical properties required for the primary mechanism of action of the contact 
lenses (if intended as vision correctors). Addition of low amounts of polymyxin B during 
synthesis to prepare imprinted networks enables modulation of the loading and release 
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profiles, but if the amount is above a certain threshold the contact lenses become translucent, 
which in turn may compromise their application as ophthalmic devices. Nevertheless, those 
translucent hydrogels might be useful for other applications that require prolonged release of 
antimicrobial agents (e.g., as constituents of topic or implantable formulations or of ocular 
inserts). In vitro microbiological tests evidenced the role that the 
monomer:template:crosslinker ratios play on having hydrogels that can effectively stand 
several challenges against common bacteria on the eye surface. Moreover, the hydrogels 
could be used for the hosting of other related antimicrobial peptides useful against common 
Gram-negative and Gram-positive bacteria responsible of ocular infections and biofilm 
formation onto contact lenses. Memorization of the imprinting may be exploited for 
rebinding and release of polymyxin B.  
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Figure captions 
 
Figure 1. Structure of polymyxin B1 (1301.56 g/mol),vancomycin (1449.30 g/mol) and 
acrylic acid monomer (AAc, 72.06 g/mol). AAc can ionically interact with amine groups 
(indicated with green arrows) and through hydrogen bonding with the atoms of peptide bond 
(purple arrows), as depicted (in red color) for two of the groups of polymyxin B.  
 
Figure 2. Polymyxin B loading profiles for different hydrogel formulations. Codes as in 
Table 1. 
 
Figure 3. Polymyxin B release profiles in 0.9% NaCl from different hydrogel formulations. 
The plot on the right shows the first 24-h time period. Codes as in Table 1. 
 
Figure 4. Inhibition zones in Pseudomonas aeruginosa cultures in agar plates recorded 
after 24 hours of incubation with: first row, 0.9% NaCl solution, polymyxin B solution (4 
mg/mL), and polymyxin B-loaded discs of hydrogels A, B, C and D (in duplicate); and 
second row, polymyxin B-loaded discs of hydrogels E, F and G (in duplicate) and samples 
of release medium from hydrogel D taken at 4 and 8 h since the beginning of the release 
test (which showed inhibition zone diameters of 1.0 and 1.6 cm, respectively). 
 
Figure 5. Vancomycin loading in water (up) and release profiles in water and in 0.9% NaCl 
(down) from different hydrogel formulations. Codes as in Table 1. The release medium was 
initially water and after 24 h it was replaced with 0.9% NaCl. Five days later, the medium 
was replaced with fresh 0.9% NaCl.  
 
Figure 6. Polymyxin B loading in water (up) and release profiles in 0.9% NaCl (down) 
from hydrogel discs that were firstly exposed to vancomycin. Codes as in Table 1.  
